Nina M. Wolf

Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus

Mary Choules, Nina M. Wolf, Hyun Lee et al. · Antimicrobial Agents and Chemotherapy · 2019 · 118 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads

Nina M. Wolf, Hyun Lee, Mary Choules et al. · ACS Infectious Diseases · 2019 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Antimycobacterial Rufomycin Analogues from <i>Streptomyces atratus</i> Strain MJM3502

Bin Zhou, Gauri Shetye, Yu Yang et al. · Journal of Natural Products · 2020 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions

Nina M. Wolf, Hyun Lee, Daniel Zagal et al. · Acta Crystallographica Section D Structural Biology · 2020 · 48 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Identification of Bacillus anthracis PurE inhibitors with antimicrobial activity

Anna Kim, Nina M. Wolf, Tian Zhu et al. · Bioorganic & Medicinal Chemistry · 2015 · 24 citations

Life Sciences, Medicinal Chemistry, Microbiology +11